Search

Metabolic engineering of thermophilic Bacillus licheniformis for chiral pure D-2,3-butanediol production

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 고무
      2. 플라스틱
    • 바이오정밀화학
      1. 용매
      2. 화학제품
      3. 연료
    • 화장품용 기능성소재
      1. 계면활성제⁄증점제
    • 의료용 화학소재
      1. 식품첨가제
논문

Metabolic engineering of thermophilic Bacillus licheniformis for chiral pure D-2,3-butanediol production

학술지

Biotechnology and bioengineering

저자명

Wang, Qingzhao; Chen, Tao; Zhao, Xueming; Chamu, Jauhleene

초록

<P><B>Abstract</B></P><P>2,3&#8208;Butanediol is an important compound that can be used in many areas, especially as a platform chemical and liquid fuel. But traditional 2,3&#8208;butanediol producing microorganisms, such as <I>Klebsiella pneumonia</I> and <I>K. xoytoca</I>, are pathogens and they can only ferment sugars at 37&deg;C. Here, we reported a newly developed <I>Bacillus licheniformis</I>. A protoplast transformation system was developed and optimized for this organism. With this transformation method, a marker&#8208;less gene deletion protocol was successfully used to knock out the <I>ldh</I> gene of <I>B. licheniformis</I> BL1 and BL3. BL1 was isolated earlier from soil for lactate production and it was further evolved to BL3 for xylose utilization. Combined with pH and aeration control, <I>ldh</I> mutant BL5 and BL8 can efficiently ferment glucose and xylose to <SMALL>D</SMALL>&#8208;(&minus;) 2,3&#8208;butanediol at 50&deg;C, pH 5.0. For glucose and xylose, the specific 2,3&#8208;butanediol productivities are 29.4 and 26.1&thinsp;mM/h, respectively. The yield is 0.73&thinsp;mol/mol for BL8 in xylose and 0.9&thinsp;mol/mol for BL5 and BL8 in glucose. The <SMALL>D</SMALL>&#8208;(&minus;) 2,3&#8208;butanediol optical purity is more than 98%. As far as we know, this is the first reported high temperature butanediol producer to match the simultaneous saccharification and fermentation conditions. Therefore, it has potential to further lower butanediol producing cost with low cost lignocellulosic biomass in the near future. Biotechnol. Bioeng. 2012; 109:1610&ndash;1621. &copy; 2012 Wiley Periodicals, Inc.</P>

발행연도

2012

발행기관

Wiley Subscription Services, Inc., A Wiley Company

ISSN

0006-3592

ISSN

1097-0290

109

7

페이지

pp.1610-1621

주제어

Bacillus licheniformis; 2,3&#x2010; butanediol; metabolic engineering;

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

5건의 후보군 물질이 있습니다.

1 2023-12-11
2 2023-12-11
3 2023-12-11
4 2023-12-11
5 2023-12-11

논문; 2012-01-10

Export

About

Search

Trend